CalciMedica, Inc.
- CALC
- NASDAQ
- Biotechnology
- Inflammation Therapeutics
- CRAC Channel Inhibitors
$1.04
Today −3.70%Quote Oct 16, 2026, 08:00 PM UTC
−47.21%over the last month
Max drawdown −47.2%From 1-month high −47.2%3 months −70.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$35.5M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$266.00
+25476.9% from here
Floor
$1.03
1.0% below price
Where the price sits
3 analysts
Analyst range, low to high
$14.00$392.00
- Price $1.04
- Resistance $1.15
- Consensus $266.00
The price is just above its floor. Analysts' average target sits about 25477% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CALCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
15